The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification
Open accessAbstract
Circulating cell-free DNA (cfDNA) is becoming an important clinical analyte for prenatal testing, cancer diagnosis and cancer monitoring. The extraction stage is critical in ensuring clinical sensitivity of analytical methods measuring minority nucleic acid fractions, such as foetal-derived sequences in predominantly maternal cfDNA. Consequently, quality controls are required for measurement of extraction efficiency, fragment size bias and yield for validation of cfDNA methods. We evaluated the utility of an external DNA spike for monitoring these parameters in a study comparing three specific cfDNA extraction methods [QIAamp circulating nucleic acid (CNA) kit, NucleoSpin Plasma XS (NS) kit and FitAmp plasma/serum DNA isolation (FA) kit] with the commonly used QIAamp DNA blood mini (DBM) kit. We found that the extraction efficiencies of the kits ranked in the order CNA kit > DBM kit > NS kit > FA kit, and the CNA and NS kits gave a better representation of smaller DNA fragments in the extract than the DBM kit. We investigated means of improved reporting of cfDNA yield by comparing quantitative PCR measurements of seven different reference gene assays in plasma samples and validating these with digital PCR. We noted that the cfDNA quantities based on measurement of some target genes (e.g. TERT) were, on average, more than twofold higher than those of other assays (e.g. ERV3). We conclude that analysis and averaging of multiple reference genes using a GeNorm approach gives a more reliable estimate of total cfDNA quantity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments
Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M. W., Shipley, G. L., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112797 · Cited by 16,303
Self-citationHigh-throughput droplet digital PCR system for absolute quantitation of DNA copy number
Hindson, B. J., Ness, K. D., Masquelier, D. A., Belgrader, P., Heredia, N. J., Makarewicz, A. J., Bright, I. J., Lucero, M. Y., Hiddessen, A. L., Legler, T. C., et al. (2011) · Analytical Chemistry · doi:10.1021/ac202028g · Cited by 2,792
Real-time RT-PCR normalisation; strategies and considerations
Huggett, J., Dheda, K., Bustin, S., & Zumla, A. (2005) · Genes & Immunity · doi:10.1038/sj.gene.6364190 · Cited by 1,856
Self-citationA highly conserved repetitive DNA sequence,(TTAGGG) n, present at the telomeres of human chromosomes
Moyzis, R. K., Buckingham, J. M., Cram, L. S., Dani, M., Deaven, L. L., Jones, M. D., Meyne, J., Ratliff, R. L., & Wu, J. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6622 · Cited by 1,820
Liquid biopsy: monitoring cancer-genetics in the blood
Crowley, E., Di Nicolantonio, F., Loupakis, F., & Bardelli, A. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.110 · Cited by 1,819
(1977) · PubMed · Cited by 1,801
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Murtaza, M., Dawson, S.-J., Tsui, D. W. Y., Gale, D., Forshew, T., Piskorz, A. M., Parkinson, C., Chin, S.-F., Kingsbury, Z., Wong, A. S. C., et al. (2013) · Nature · doi:10.1038/nature12065 · Cited by 1,624
Forshew, T., Murtaza, M., Parkinson, C., Gale, D., Tsui, D. W. Y., Kaper, F., Dawson, S.-J., Piskorz, A. M., Jimenez-Linan, M., Bentley, D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003726 · Cited by 1,297
Non-Invasive Analysis of Acquired Resistance to Cancer Therapy By Sequencing of Plasma Dna
(2014) · Annals of Oncology · doi:10.1093/annonc/mdu312.5 · Cited by 1,169
Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction.
Bustin, S. A., & Nolan, T. (2004) · PubMed · Cited by 1,041
Purification and Characterization of PCR-Inhibitory Components in Blood Cells
Al-Soud, W. A., & Rådström, P. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.2.485-493.2001 · Cited by 944
Huggett, J. F., Foy, C. A., Benes, V., Emslie, K., Garson, J. A., Haynes, R., Hellemans, J., Kubista, M., Mueller, R. D., Nolan, T., et al. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.206375 · Cited by 859 · cited 2×
“The mean number of copies per droplet (λ) was estimated using the relationship λ=−ln(1 −m/n), which assumes a Poisson distribution for the number of copies in each droplet (Table S5) [43, 44].”
MethodSelf-citationCirculating nucleic acids (CNAs) and cancer—A survey
Fleischhacker, M., & Schmidt, B. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.10.001 · Cited by 851
Taly, V., Pekin, D., Benhaim, L., Kotsopoulos, S. K., Le Corre, D., Li, X., Atochin, I., Link, D. R., Griffiths, A. D., Pallier, K., et al. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.206359 · Cited by 492
Whale, A. S., Huggett, J. F., Cowen, S., Speirs, V., Shaw, J., Ellison, S., Foy, C. A., & Scott, D. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks203 · Cited by 453 · cited 2×
“91 nL per droplet, and confidence intervals were calculated as described previously [45].”
MethodSelf-citationGormally, E., Caboux, E., Vineis, P., & Hainaut, P. (2007) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2006.11.002 · Cited by 445
Digital PCR for the molecular detection of fetal chromosomal aneuploidy
Lo, Y. M. D., Lun, F. M. F., Chan, K. C. A., Tsui, N. B. Y., Chong, K. C., Lau, T. K., Leung, T. Y., Zee, B. C. Y., Cantor, C. R., & Chiu, R. W. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705765104 · Cited by 434
Amniocentesis and chorionic villus sampling for prenatal diagnosis
Alfirevic, Z., Navaratnam, K., & Mujezinovic, F. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003252.pub2 · Cited by 412
Noninvasive Whole-Genome Sequencing of a Human Fetus
Kitzman, J. O., Snyder, M. W., Ventura, M., Lewis, A. P., Qiu, R., Simmons, L. E., Gammill, H. S., Rubens, C. E., Santillan, D. A., Murray, J. C., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004323 · Cited by 411
Non-invasive prenatal measurement of the fetal genome
Fan, H. C., Gu, W., Wang, J., Blumenfeld, Y. J., El-Sayed, Y. Y., & Quake, S. R. (2012) · Nature · doi:10.1038/nature11251 · Cited by 392
Giacona, M. B., Ruben, G. C., Iczkowski, K. A., Roos, T. B., Porter, D. M., & Sorenson, G. D. (1998) · Pancreas · doi:10.1097/00006676-199807000-00012 · Cited by 387
Universal noninvasive detection of solid organ transplant rejection
Snyder, T. M., Khush, K. K., Valantine, H. A., & Quake, S. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013924108 · Cited by 385
Isolation and characterization of DNA from the plasma of cancer patients
Stroun, M., Anker, P., Lyautey, J., Lederrey, C., & Maurice, P. A. (1987) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(87)90266-5 · Cited by 373 · cited 1×
“The discovery of cell-free DNA (cfDNA) in blood has provided an accessible source of genetic material from foetal tissue [1], solid tumours [2, 3] or solid organ transplants [4].”
BackgroundEffects of Blood-Processing Protocols on Fetal and Total DNA Quantification in Maternal Plasma
Chiu, R. W. K., Poon, L. L. M., Lau, T. K., Leung, T. N., Wong, E. M. C., & Lo, Y. M. D. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.9.1607 · Cited by 351
Evaluation of digital PCR for absolute DNA quantification
Sanders, R., Huggett, J. F., Bushell, C. A., Cowen, S., Scott, D. J., & Foy, C. A. (2011) · Analytical Chemistry · doi:10.1021/ac103230c · Cited by 338
Self-citationComparison of Droplet Digital PCR to Real-Time PCR for Quantitative Detection of Cytomegalovirus
Hayden, R. T., Gu, Z., Ingersoll, J., Abdul-Ali, D., Shi, L., Pounds, S., & Caliendo, A. M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02620-12 · Cited by 335
Non‐invasive prenatal testing for aneuploidy: current status and future prospects
Benn, P., Cuckle, H., & Pergament, E. (2013) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.12513 · Cited by 326
Increased plasma DNA integrity in cancer patients.
Wang, B. G., Huang, H. Y., Chen, Y., Bristow, R. E., Kassauei, K., Cheng, C., Roden, R. B. S., Sokoll, L. J., Chan, D. W., & Shih, I. (2003) · PubMed · Cited by 326
Prognostic utility and characterization of cell-free DNA in patients with severe sepsis
Dwivedi, D. J., Toltl, L. J., Swystun, L. L., Pogue, J., Liaw, K.-L., Weitz, J. I., Cook, D. J., Fox-Robichaud, A. E., Liaw, P. C., & the Canadian Critical Care Translational Biology Group (2012) · Critical Care · doi:10.1186/cc11466 · Cited by 306
Alu elements as regulators of gene expression
Häsler, J., & Strub, K. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl706 · Cited by 299
Sequence organization of the human genome
Schmid, C. W., & Deininger, P. L. (1975) · Cell · doi:10.1016/0092-8674(75)90184-1 · Cited by 296
Beck, J., Bierau, S., Balzer, S., Andag, R., Kanzow, P., Schmitz, J., Gaedcke, J., Moerer, O., Slotta, J. E., Walson, P., et al. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.210328 · Cited by 271
Differential susceptibility of PCR reactions to inhibitors: an important and unrecognised phenomenon
Huggett, J. F., Novak, T., Garson, J. A., Green, C., Morris-Jones, S. D., Miller, R. F., & Zumla, A. (2008) · BMC Research Notes · doi:10.1186/1756-0500-1-70 · Cited by 250 · cited 1×
“This is in agreement with our earlier observations [51].”
ResultSelf-citationDigital PCR Analysis of Maternal Plasma for Noninvasive Detection of Sickle Cell Anemia
Barrett, A. N., McDonnell, T. C. R., Chan, K. C. A., & Chitty, L. S. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.178939 · Cited by 200
Influence of Plasma Processing on Recovery and Analysis of Circulating Nucleic Acids
Page, K., Guttery, D. S., Zahra, N., Primrose, L., Elshaw, S. R., Pringle, J. H., Blighe, K., Marchese, S. D., Hills, A., Woodley, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077963 · Cited by 187
Circulating nucleic acids in plasma/serum
Tsang, J. C. H., & Dennis Lo, Y. M. (2007) · Pathology · doi:10.1080/00313020701230831 · Cited by 181
Noninvasive Detection of HER2 Amplification with Plasma DNA Digital PCR
Gevensleben, H., Garcia-Murillas, I., Graeser, M. K., Schiavon, G., Osin, P., Parton, M., Smith, I. E., Ashworth, A., & Turner, N. C. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3768 · Cited by 172
Optimizing the yield and utility of circulating cell-free DNA from plasma and serum
Xue, X., Teare, M. D., Holen, I., Zhu, Y. M., & Woll, P. J. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.02.018 · Cited by 171
Birch, L., English, C. A., O’Donoghue, K., Barigye, O., Fisk, N. M., & Keer, J. T. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.042713 · Cited by 144
Wong, D. T., Moturi, S., Angkachatchai, V., Mueller, R. D., DeSantis, G., van den Boom, D., & Ehrich, M. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.04.023 · Cited by 133
Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients
Marzese, D. M., Hirose, H., & Hoon, D. S. �. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2013.845088 · Cited by 131
Methods for isolation of cell-free plasma DNA strongly affect DNA yield
Fleischhacker, M., Schmidt, B., Weickmann, S., Fersching, D. M. I., Leszinski, G. S., Siegele, B., Stötzer, O. J., Nagel, D., & Holdenrieder, S. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.07.011 · Cited by 126
Barrett, A. N., Zimmermann, B. G., Wang, D., Holloway, A., & Chitty, L. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025202 · Cited by 118
Isolation and Extraction of Circulating Tumor DNA from Patients with Small Cell Lung Cancer
Ruth E. Board, Williams, V. S., Knight, L., Shaw, J., Greystoke, A., Ranson, M., Dive, C., Blackhall, F. H., & Hughes, A. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.020 · Cited by 106
Origin of Plasma Cell-free DNA after Solid Organ Transplantation
Lui, Y. Y.-N., Woo, K. S., Wang, A. Y.-M., Yeung, C.-K., Li, P. K., Chau, E. M. C., Ruygrok, P., & Lo, Y. M. D. (2003) · Clinical Chemistry · doi:10.1373/49.3.495 · Cited by 101
Gotoh, T., Hosoi, H., Iehara, T., Kuwahara, Y., Osone, S., Tsuchiya, K., Ohira, M., Nakagawara, A., Kuroda, H., & Sugimoto, T. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.014 · Cited by 93
Detection of HER2 amplification in circulating free DNA in patients with breast cancer
Page, K., Hava, N., Ward, B., Brown, J., Guttery, D. S., Ruangpratheep, C., Blighe, K., Sharma, A., Walker, R. A., Coombes, R. C., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.89 · Cited by 86
Influence of Temperature during Transportation on Cell-Free DNA Analysis
Hidestrand, M., Stokowski, R. P., Song, K., Oliphant, A., Deavers, J., Goetsch, M. A., Simpson, P. M., Kuhlmann, R. S., Ames, M. B., Mitchell, M., et al. (2012) · Fetal Diagnosis and Therapy · doi:10.1159/000335020 · Cited by 72
Fong, S. L., Zhang, J. T., Lim, C. K., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.110122 · Cited by 70
Pinzani, P., Salvianti, F., Cascella, R., Massi, D., GIORGI, V. D., Pazzagli, M., & Orlando, C. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.05.024 · Cited by 65
Improved Method for Isolating Cell-Free DNA
Schmidt, B., Weickmann, S., Witt, C. C., & Fleischhacker, M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.051003 · Cited by 63
Circulating nucleic acids in cancer and pregnancy
Pinzani, P., Salvianti, F., Pazzagli, M., & Orlando, C. (2010) · Methods · doi:10.1016/j.ymeth.2010.02.004 · Cited by 60
Implications of Storing Urinary DNA from Different Populations for Molecular Analyses
Cannas, A., Kalunga, G., Green, C. K., Calvo, L., Katemangwe, P., Reither, K., Perkins, M. D., Maboko, L., Höelscher, M., Talbot, E. A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006985 · Cited by 53
Self-citationMutant DNA in Plasma of Lung Cancer Patients: Potential for Monitoring Response to Therapy
Kimura, T., Holland, W. S., Kawaguchi, T., Williamson, S. K., Chansky, K., Crowley, J. J., Doroshow, J. H., Lenz, H., Gandara, D. R., & Gumerlock, P. H. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1318.010 · Cited by 52
Aung, K. L., R. E. Board, Ellison, G., Donald, E. L., Ward, T. H., Clack, G., Ranson, M., Hughes, A. M., Newman, W. G., & Dive, C. (2010) · The HUGO Journal · doi:10.1007/s11568-011-9149-2 · Cited by 46
Hahn, S., Jackson, L. G., Kolla, V., Mahyuddin, A. P., & Choolani, M. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.43 · Cited by 32 · cited 1×
“The discovery of cell-free DNA (cfDNA) in blood has provided an accessible source of genetic material from foetal tissue [1], solid tumours [2, 3] or solid organ transplants [4].”
BackgroundFox, B. C., Devonshire, A. S., Schutte, M. E., Foy, C. A., Minguez, J., Przyborski, S. A., Maltman, D. J., Bokhari, M., & Marshall, D. (2010) · Toxicology in Vitro · doi:10.1016/j.tiv.2010.08.007 · Cited by 26
Self-citationBuysse, K., Beulen, L., Gomes, I., Gilissen, C., Keesmaat, C., Janssen, I. M., Willemen, J. J., de Ligt, J., Feenstra, I., Bekker, M. N., et al. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.07.020 · Cited by 16
Isolation of Cell-Free DNA from Maternal Plasma Using Manual and Automated Systems
Huang, D. J., Mergenthaler‐Gatfield, S., Hahn, S., et al. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-066-9_15 · Cited by 13
Cited by
Integrating liquid biopsies into the management of cancer
Siravegna, G., Marsoni, S., Siena, S., & Bardelli, A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.14 · Cited by 1,908
Circulating Tumor DNA as a Liquid Biopsy for Cancer
Heitzer, E., Ulz, P., & Geigl, J. B. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.222679 · Cited by 767
Considerations for Digital PCR as an Accurate Molecular Diagnostic Tool
Huggett, J. F., Cowen, S., & Foy, C. A. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.221366 · Cited by 444
Self-citationGorgannezhad, L., Umer, M., Islam, M. N., Nguyen, N.-T., & Shiddiky, M. J. A. (2018) · Lab on a Chip · doi:10.1039/c8lc00100f · Cited by 312
Guidelines for the Preanalytical Conditions for Analyzing Circulating Cell-Free DNA
Meddeb, R., Pisareva, E., & Thierry, A. R. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2018.298323 · Cited by 262
Metadata
- Authors
- Devonshire, A. S., Whale, A. S., Gutteridge, A., Jones, G., Cowen, S., Foy, C. A., & Huggett, J. F.
- Venue
- Analytical and Bioanalytical Chemistry
- Published
- 2014-05-24
- Volume
- 406
- Issue
- 26
- Pages
- 6499-6512
- ISSN
- 1618-2642 (ISSN-L)
- 1618-2650
- OpenAlex
- W2082540681
- Cited by
- 299
- References
- 61
- FWCI
- 20.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.